Drug Pipeline

Senicapoc Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT04804241 Senicapoc in Alzheimer's Disease Mild Cognitive Impairment Recruiting
NCT06714123 Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease Pulmonary Fibrosis, Interstitial Lung Disease Recruiting
Early Phase 1
NCT07284069 Senicapoc and Perampanel for Newly Diagnosed Glioblastoma Glioblastoma Recruiting
Sponsors Running Senicapoc Trials
University of California, Davis (1) Vejle Hospital (1) Aarhus University Hospital (1)
Disease Areas
Alzheimer's Disease (1) Idiopathic Pulmonary Fibrosis (1) Glioblastoma (1)
Get alerts when Senicapoc trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free